Livzon Pharmaceutical Group Inc. (HKG:1513)
31.26
+0.54 (1.76%)
Oct 31, 2025, 4:08 PM HKT
HKG:1513 Market Cap
HKG:1513 has a market cap or net worth of 33 billion as of October 31, 2025. Its market cap has decreased by -9.71% in one year.
Market Cap
33.00B
Enterprise Value
26.75B
Revenue
12.95B
Ranking
n/a
PE Ratio
14.09
Stock Price
31.26
Market Cap Chart
Since July 14, 1997, HKG:1513's market cap has increased from 365.70M to 33.00B, an increase of 8,924.72%. That is a compound annual growth rate of 17.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 33.00B | 1.01% |
| Dec 31, 2024 | 32.67B | 4.83% |
| Dec 29, 2023 | 31.17B | 0.42% |
| Dec 30, 2022 | 31.04B | -21.73% |
| Dec 31, 2021 | 39.66B | 0.71% |
| Dec 31, 2020 | 39.38B | 27.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.63B |
| Hansoh Pharmaceutical Group Company | 215.76B |
| JD Health International | 194.33B |
| WuXi Biologics | 148.69B |
| Innovent Biologics | 138.28B |
| Sino Biopharmaceutical | 122.81B |
| Akeso | 104.46B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |